Skip to main content

Announcements

Displaying 133 - 138 of 138 announcements
London COVID-19 dexamethasone and hyperglycaemia: diabetes de-escalation guidance

Dr. Dipesh Patel

Released on 20th January 2021 by London NHS, London COVID-19 dexamethasone and hyperglycaemia: diabetes de-escalation guidance is now available for download.

Covid-19 update: Guidance and Resources for primary care and patients

Dr. Dipesh Patel

The statement from PCDS, supported by ABCD and Diabetes UK contains useful updated information to share with community colleagues and patients.  

ABCD and ABHI Position on Insulin Pumps

Professor Pratik Choudhary

ABCD and ABHI have released a joint position statement "Supporting Management of People with diabetes using Out-of-Warranty Pumps while Ensuring Appropriate Patient Choice". The COVID-19 pandemic has…

Covid wave 2

Dr. Dipesh Patel

This new year, we find ourselves in perilous times managing a recurrent viral surge (resulting from a mutated strain) which seems to be steeper than the last. Vulnerable elderly people and front-line…

Call for Members to support the ACCEA scoring for ABCD

Dr. Susannah Rowles

Calling all ABCD members who hold a National Clinical Excellence Award (CEA) award….. Your help is needed urgently! CEA’s were paused during 2020 due to the pandemic but now the process for citation…

Launch of ABCD worldwide audit of testosterone deficiency in men with type 2 diabetes

Dr. Bob Ryder

This week at the ABCD Conference 2020, ABCD is pleased to announce the launch of the ABCD worldwide audit of testosterone deficiency in men with type 2 diabetes.  The condition has a high…

Looking for something older? Our announcement archive contains announcements older than three years.

photo of announcement author, Professor Ketan Dhatariya
Professor Ketan Dhatariya, Consultant in diabetes and endocrinology, honorary professor of medicine,
I am delighted to announce that ABCD and the Primary Care Diabetes Society (PCDS) have formally agreed to collaborate in certain of the nationwide audits of new diabetes therapies and devices. …